Evidence map›Paper›PMID 41623170›Full record

ReviewThe Journal of clinical investigation2026

Illuminating retinoid flux in the neurosensory retina.

Ala Moshiri, Akrit Sodhi

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ala MoshiriDepartment of Ophthalmology and Vision Science, School of Medicine, University of California, Davis, Sacramento, California, USA.
Akrit SodhiWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Funding

Intravitreal gene therapy for inherited retinal diseaseR01EY034123 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ALA MOSHIRI · 2023 to 2026
$2.7M
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal DiseaseR01EY029750 · NEI · JOHNS HOPKINS UNIVERSITY · PI SODHI, AKRIT SINGH · 2019 to 2023
$2.6M
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucomaR01EY032104 · NEI · UNIVERSITY OF MARYLAND BALTIMORE · PI MONTANER, SILVIA V, SODHI, AKRIT SINGH · 2021 to 2024
$2.3M
Hypoxia Inducible Factors and Hypoglycemia in Early Diabetic Eye DiseaseR01EY035889 · NEI · JOHNS HOPKINS UNIVERSITY · PI Akrit Singh Sodhi · 2024 to 2026
$1.5M
NEI NIH HHS R01 EY029750NEI NIH HHS R01 EY032104NEI NIH HHS R01 EY034123NEI NIH HHS R01 EY035889
6 · The paper itself

Abstract

The retinoid chromophore 11-cis-retinal triggers an intracellular cascade known as phototransduction that converts light into electrochemical signals. Enzymatic regeneration of 11-cis-retinal sustains vision, prevents the buildup of toxic byproducts, and is supported largely by the retinal pigmented epithelium. Directly visualizing rapidly changing retinoid intermediates in patients with inherited retinal diseases (IRDs) could provide essential therapeutic insights. In this issue, Engfer et al. introduced a groundbreaking strategy using the mouse retina as a genetically malleable model for the mammalian eye. Using cell-specific expression of lecithin:retinol acyltransferase to trap mobile retinols, they mapped the availability of 11-cis- and all-trans-retinoids within different retinal compartments under normal and diseased conditions. Their findings elucidate retinoid distribution in the retina and highlight important differences between mouse and human Müller glia. Here, we contextualize these advances within decades of research defining the visual cycle and retinoid biology, outlining the profound implications for therapeutic development for IRDs.

Indexed as

Ependymoglial CellsRetinaRetinal DiseasesRetinoidsAcyltransferasesAnimalsHumansMiceRetinaldehydeVision, OcularAcyltransferaseslecithin-retinol acyltransferaseRetinaldehydeRetinoids

Identifiers

PMID41623170
PMCPMC12867152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.